Hanson Kristopher 4
4 · MapLight Therapeutics, Inc. · Filed Jan 29, 2026
Research Summary
AI-generated summary of this filing
MapLight (MPLT) GC Kristopher Hanson Withholds 26,007 Shares for Taxes
What Happened Kristopher Hanson, General Counsel of MapLight Therapeutics, had 26,007 shares withheld by the issuer on 2026-01-27 to satisfy tax withholding obligations related to the settlement of restricted stock units (RSUs). The filing shows a per-share value of $17.98, for a total of $467,606. This was a tax-withholding disposition (code F), not an open-market sale or new purchase.
Key Details
- Transaction date: January 27, 2026
- Price used for withholding: $17.98 per share
- Shares withheld/disposed: 26,007 (reported as disposition under tax withholding) — total value ~$467,606
- Shares owned after the transaction: not specified in the provided filing summary
- Footnote: The shares were withheld to satisfy tax obligations on RSU settlement. Retained shares remain subject to a 180-day lock-up from the IPO prospectus date (Oct 26, 2025), which generally prevents sales until ~Apr 23, 2026.
- Filing timeliness: Form 4 filed on Jan 29, 2026 for the Jan 27 transaction (within the typical two-business-day filing window).
Context This was a routine tax-withholding transaction tied to RSU settlement (often called a cashless or share-withholding method) rather than a discretionary sale on the open market. Such withholdings are common and generally do not by themselves indicate insider sentiment about the stock. The lock-up noted in the footnote restricts resale of the retained securities until the lock-up period expires.
Insider Transaction Report
- Tax Payment
Voting Common Stock
[F1]2026-01-27$17.98/sh−26,007$467,606→ 183,852 total
Footnotes (1)
- [F1]Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock unit awards. The securities of the Issuer retained by the Reporting Person remain subject to the terms a lock-up agreement entered into with the underwriters for the Issuer's initial public offering, pursuant to which the Reporting Person agreed, subject to certain exceptions, not to directly or indirectly sell or otherwise transfer securities of the Issuer for a period of 180 days following the date of the final prospectus relating to the initial public offering, which was October 26, 2025.